Future of Bioorthogonal-Chemistry for Targeting of Exosomes in Precision Medicine

Posted by

Oncotarget

Oncotarget published this editorial perspective in Volume 13, entitled, “The future of bioorthogonal-chemistry for targeting of exosomes in precision medicine" by Mujib Ullah from Institute for Immunity and Transplantation, Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Palo Alto, CA; Molecular Medicine Department of Medicine, Stanford University, CA. DOI - https://doi.org/10.18632/oncotarget.28323 Correspondence to - Mujib Ullah - ullah@stanford.edu Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28323 Keywords - precision medicine, bioorthogonal, exosomes About Oncotarget Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form, and then quickly released to Pubmed. On September 15, 2022, Oncotarget was accepted again for indexing by MEDLINE. Oncotarget is now indexed by Medline/PubMed and PMC/PubMed. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/OncotargetYouTube LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957